Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue SUPPL. 1, 2006, Pages 423-429

  Müller, Hermann L ^a   Müller Stöver, Sarah ^b   Gebhardt, Ursel ^a   Kolb, Reinhard ^a   Sörensen, Niels ^b   Handwerker, Georg ^b  

^a KLINIKUM OLDENBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Craniopharyngioma; Daytime sleepiness; Hypopituitarism; Hypothalamus; Obesity; Polysomnography; Secondary narcolepsy

Indexed keywords

OREXIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COHORT ANALYSIS; CRANIOPHARYNGIOMA; DAYTIME SOMNOLENCE; DISEASE EXACERBATION; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; HYPERSOMNIA; HYPOTHALAMUS FUNCTION DISORDER; MALE; NARCOLEPSY; OBESITY; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; REM SLEEP; RISK ASSESSMENT; RISK FACTOR; SLEEP DISORDERED BREATHING;

ADOLESCENT; ADULT; BODY MASS INDEX; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COHORT STUDIES; CRANIOPHARYNGIOMA; FEMALE; HLA ANTIGENS; HUMANS; MALE; NARCOLEPSY; OBESITY; PITUITARY NEOPLASMS; POLYSOMNOGRAPHY; RISK FACTORS; SLEEP; SLEEP STAGES;

EID: 33646167203     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Einhaus SL, Sanford RA. Craniopharyngiomas. In: Albright AL, Pollack IF, Adelson PD, eds. Principles and Practice of Pediatric Neurosurgery. New York-Stuttgart: Thieme, 1999; 545-562.
2. Müller HL, Kaatsch P, Warmuth-Metz M, Flentje M, Sörensen N. Childhood craniopharyngioma - current concepts in diagnostics and therapy. Monatsschr Kinderheilkd 2003; 151: 1056-1063.
3. Müller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, Korinthenberg R, Bettendorf M, Kühl J, Gutjahr P, Sörensen N, Calaminus G. Obesity after childhood craniopharyngioma - German multicenter study on preoperative risk factors and quality of life. Klin Padiatr 2001; 213: 244-249.
4. Müller HL, Heinrich M, Bueb K, Etavard-Gorris N, Gebhardt U, Kolb R, Sörensen N. Perioperative dexamethasone treatment in childhood craniopharyngioma-influence on short-term and long-term weight development. J Exp Clin Endocrinol Diabetes 2003; 111: 330-334.
5. Müller HL, Schneider P, Bueb K, Etavard-Gorris N, Gebhardt U, Kolb R, Sörensen N. Volumetric bone mineral density in patients with childhood craniopharyngioma. J Exp Clin Endocrinol Diabetes 2003; 111: 168-173.
6. Roth C, Lakomek M, Müller HL, Harz KJ. Obesity in children - etiology and treatment. Monatsschr Kinderheilkd 2002; 150: 329-336.
7. Müller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sörensen N. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 2004; 89: 3298-3305.
8. Müller HL, Faldum A, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sörensen N. Functional capacity, obesity and hypothalamic involvement-cross-sectional study on 212 patients with childhood craniopharyngioma. Klin Padiatr 2003; 215: 310-314.
9. Müller HL, Handwerker G, Wollny B, Sörensen N. Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab 2002; 87: 3993-3996.
10. Harz K, Müller HL, Waldeck E, Pudel V, Roth C. Obesity in patients with craniopharyngioma: assessment of physical activity and food intake. J Clin Endocrinol Metab 2003; 88: 5227-5231.
11. Müller HL, Handwerker G, Gebhardt U, Faldum A, Emser A, Kolb R, Sörensen N. Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness. Cancer Causes Control 2006; in press.
12. Bloch KE, Schoch OD, Zhang JN, Russi EW. German version of the Epworth Sleepiness Scale. Respiration 1999; 66: 440-447.
13. Rolland-Cachera MF, Cole TJ, Sempé Tichet J, Rossignol C, Charraud A. Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 1991; 45: 13-21.
14. Horne JA, Östberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 1976; 4: 97-110.
15. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles, CA: Brain Information Service/Brain Research Institute, 1968.
16. Flynn FG, Cummings JL, Tomiyasu U. Altered behavior associated with damage to the ventromedial hypothalamus: a distinctive syndrome. Behav Neurol 1988; 1: 49-58.
17. Roth C, Wilken B, Hanefeld F, Schröter W, Leonhardt U. Hyperphagia in children with craniopharyngioma is associated with hyperleptinemia and a failure in the downregulation of appetite. Eur J Endocrinol 1998; 138: 89-91.
18. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999; 98: 365-376.
19. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999; 98: 437-451.
20. Wagner D, Salin-Pascual R, Greco MA, Shiromani PJ. Distribution of hypocretin-containing neurons in the lateral hypothalamus and c-fos-immunoreactive neurons in the VLPO. Sleep Research Online 2000; 3: 35-42.
21. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355: 39-40.
22. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nature Med 2000; 6: 991-997.
23. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000; 27: 469-474.
24. John J, Wu M-F, Siegel JM. Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs. Sleep Research Online 2000; 3: 23-28.
25. Garcia-Borreguero D, Wehr TA, Larrosa O, Granizo JJ, Hardwick D, Chrousos GP, Friedman TC. Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency. J Clin Endocrinol Metab 2000; 85: 4201-4206.
26. Marcus CL, Trescher WH, Halbower AC, Lutz J. Secondary narcolepsy in children with brain tumors. Sleep 2002; 25: 435-439.
27. Krahn LE, Boeve BF, Oliver L, Silver MH. Hypocretin (orexin) and melatonin values in a narcoleptic-like sleep disorder after pinealectomy. Sleep Med 2002; 3: 521-523.
28. Anderson M, Salmon MV. Symptomatic cataplexy. J Neurol Neurosurg Psychiatry 1977; 40: 186-191.
29. D'Cruz OF, Vaughn BV, Gold SH, Greenwood RS. Symptomatic cataplexy in pontomedullary lesions. Neurology 1994; 44: 2189-2199.
30. Stahl SM, Layzer RB, Aminoff MJ, Townsend JJ, Feldon S. Continuous cataplexy in a patient with a midbrain tumor: the limp man syndrome. Neurology 1980; 30: 1115-1118.
31. Ethelberg S. On cataplexy in a case of frontal lobe tumour. Acta Psychiatr Neurol Scand 1949; 24: 421-427.
32. Smith T. Cataplexy in association with meningiomas. Acta Neurol Scand Suppl 1983; 94: 45-47.
33. Minami S, Asai M, Iwahori K, Utsumi T, Kido T, Kiyoshi K. Three cases of metastatic meningeal carcinomatosis from lung cancer. Nihon Kokyuki Gakkai Zasshi 2002; 40: 513-519.
34. Müller HL, Sörensen N, eds. KRANIOPHARYGEOM 2000 - Prospective, Multicenter Surveillance Study of Children and Adolescents with Craniopharyngioma. Oldenburg: Universitätsverlag Aschenbeck & Isensee, 2001 (www.kraniopharyngeom.de).